Therefore, RUNX1 cannot directly regulate the activity of the BCL2 promoter, and the investigators found that RUNX1 can regulate BCL2 through the miR-17–92 cluster in ovarian cancer, which may be part of the mechanism via which RUNX1 regulates BCL2 to further regulate apoptosis [31]. Here, RUNX1 is linked to ovarian cancer.